Human PADI2 CRISPR gRNA in Lenti Particles
This is a Peptidyl Arginine Deiminase, Type II plasmid with gRNA insert cloned into Lentiviral VectorpLenti-U6-sgRNA-PGK-Neo. Insert length: not_set. Stable, Transient expression. Suitable for PExp and GEEN.
Bacterial selection: Ampicillin.
Catalog No. ABIN5094511
$1,450.62
Plus shipping costs $50.00, if applicable $20.00 dry ice
3 x 300 μL
Shipping to:
United States
Delivery in 31 to 42 Business Days
Quick Overview for Human PADI2 CRISPR gRNA in Lenti Particles (ABIN5094511)
Gene
PADI2
(Peptidyl Arginine Deiminase, Type II (PADI2))
Application
Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against PADI2 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- ""42 CGTGGAGGCG GTGTACGTGC 361 GATGTGGACG CAGACCGGGA 585 GAACTATCTC GTATCCGGCG ""
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of PADI2
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- PADI2 (Peptidyl Arginine Deiminase, Type II (PADI2))
-
Alternative Name
- PADI2
-
NCBI Accession
- NM_007365
Target
-
You are here:
